{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:20:55Z","timestamp":1788916855597,"version":"build-2803163510"},"reference-count":33,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"accepted":{"date-parts":[[2013,11,17]]},"published-print":{"date-parts":[[2014,3]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Perinatal hypoxia-induced free radical formation is an important cause of hypoxic-ischaemic encephalopathy and subsequent neurodevelopmental disabilities. Allopurinol reduces the formation of free radicals, which potentially limits hypoxia-induced brain damage. We investigated placental transfer and safety of allopurinol after maternal allopurinol treatment during labour to evaluate its potential role as a neuroprotective agent in suspected fetal hypoxia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>We used data from a randomised, double-blind multicentre trial comparing maternal allopurinol versus placebo in case of imminent fetal hypoxia (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT00189007\">NCT00189007<\/jats:ext-link>).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients<\/jats:title>\n                  <jats:p>We studied 58 women in labour at term, with suspected fetal hypoxia prompting immediate delivery, in the intervention arm of the study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Delivery rooms of 11 Dutch hospitals.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Intervention<\/jats:title>\n                  <jats:p>500\u2005mg allopurinol, intravenously to the mother, immediately prior to delivery.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcome measures<\/jats:title>\n                  <jats:p>Drug disposition (maternal plasma concentrations, cord blood concentrations) and drug safety (maternal and fetal adverse events).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Within 5\u2005min after the end of maternal allopurinol infusion, target plasma concentrations of allopurinol of \u22652\u2005mg\/L were present in cord blood. Of all analysed cord blood samples, 95% (52\/55) had a target allopurinol plasma concentration at the moment of delivery. No adverse events were observed in the neonates. Two mothers had a red and\/or painful arm during infusion.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>A dose of 500\u2005mg intravenous allopurinol rapidly crosses the placenta and provides target concentrations in 95% of the fetuses at the moment of delivery, which makes it potentially useful as a neuroprotective agent in perinatology with very little side effects.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration<\/jats:title>\n                  <jats:p>The study is registered in the Dutch Trial Register (NTR1383) and the Clinical Trials protocol registration system (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT00189007\">NCT00189007<\/jats:ext-link>).<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/archdischild-2013-304876","type":"journal-article","created":{"date-parts":[[2013,12,18]],"date-time":"2013-12-18T21:49:49Z","timestamp":1387403389000},"page":"F144-F148","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Rapid target allopurinol concentrations in the hypoxic fetus after maternal administration during labour"],"prefix":"10.1136","volume":"99","clinical-trial-number":[{"clinical-trial-number":"nct00189007","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00189007","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00189007","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00189007","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"J J","family":"Kaandorp","sequence":"first","affiliation":[{"name":"Department of Perinatology, University Medical Centre, Utrecht, The Netherlands"},{"name":"Diakonessen Hospital, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M P H","family":"van den Broek","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, University Medical Centre, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J N L","family":"Benders","sequence":"additional","affiliation":[{"name":"Department of Perinatology, University Medical Centre, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Oudijk","sequence":"additional","affiliation":[{"name":"Department of Perinatology, University Medical Centre, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M M","family":"Porath","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Maxima Medical Centre, Veldhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bambang Oetomo","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Maxima Medical Centre, Veldhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M G A J","family":"Wouters","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, VU University Medical Centre, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruurd","family":"van Elburg","sequence":"additional","affiliation":[{"name":"Department of Neonatology, VU University Medical Centre, Amsterdam, The Netherlands"},{"name":"Danone Research, Centre for Specialised Nutrition, Wageningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M T M","family":"Franssen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, University Medical Centre, University of Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A F","family":"Bos","sequence":"additional","affiliation":[{"name":"Department of Neonatology, University of Groningen, University Medical Centre, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B W J","family":"Mol","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Amsterdam Medical Centre, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G H A","family":"Visser","sequence":"additional","affiliation":[{"name":"Department of Perinatology, University Medical Centre, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"van Bel","sequence":"additional","affiliation":[{"name":"Department of Perinatology, University Medical Centre, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C M A","family":"Rademaker","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, University Medical Centre, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J B","family":"Derks","sequence":"additional","affiliation":[{"name":"Department of Perinatology, University Medical Centre, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the ALLO-trial Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,12,18]]},"reference":[{"key":"2025090503503756000_99.2.F144.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041996"},{"key":"2025090503503756000_99.2.F144.2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1995.118"},{"key":"2025090503503756000_99.2.F144.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17946-X"},{"key":"2025090503503756000_99.2.F144.4","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2008.0678"},{"key":"2025090503503756000_99.2.F144.5","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-10-8"},{"key":"2025090503503756000_99.2.F144.6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/14767058.2010.505052","article-title":"Pharmacological neuroprotection after perinatal asphyxia","volume":"23","author":"Fan","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2025090503503756000_99.2.F144.7","doi-asserted-by":"publisher","DOI":"10.1159\/000336378"},{"key":"2025090503503756000_99.2.F144.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2011.12.052"},{"key":"2025090503503756000_99.2.F144.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2008.04.007"},{"key":"2025090503503756000_99.2.F144.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2006.05189.x"},{"key":"2025090503503756000_99.2.F144.11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-0269"},{"key":"2025090503503756000_99.2.F144.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2005.06.031"},{"key":"2025090503503756000_99.2.F144.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(02)03145-1"},{"key":"2025090503503756000_99.2.F144.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1341-8076.2005.00266.x"},{"key":"2025090503503756000_99.2.F144.15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1542\/peds.98.1.103","article-title":"Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury","volume":"98","author":"Saugstad","year":"1996","journal-title":"Pediatrics"},{"key":"2025090503503756000_99.2.F144.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2009.09.061"},{"key":"2025090503503756000_99.2.F144.17","doi-asserted-by":"publisher","DOI":"10.1097\/00008480-200212000-00002"},{"key":"2025090503503756000_99.2.F144.18","doi-asserted-by":"publisher","DOI":"10.1053\/siny.1999.0113"},{"key":"2025090503503756000_99.2.F144.19","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199004000-00003"},{"issue":"(4 Pt 1)","key":"2025090503503756000_99.2.F144.20","first-page":"405","article-title":"Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats","volume":"33","author":"Palmer","year":"1993","journal-title":"Pediatr Res"},{"key":"2025090503503756000_99.2.F144.21","doi-asserted-by":"publisher","DOI":"10.1080\/14767050500127716"},{"key":"2025090503503756000_99.2.F144.22","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1996.03116.x"},{"key":"2025090503503756000_99.2.F144.23","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2011-300356"},{"key":"2025090503503756000_99.2.F144.24","doi-asserted-by":"publisher","DOI":"10.1016\/0020-7292(87)90012-9"},{"key":"2025090503503756000_99.2.F144.25","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-2228"},{"key":"2025090503503756000_99.2.F144.26","first-page":"130","article-title":"Treatment of mothers with allopurinol to produce therapeutic blood levels in newborns","volume":"4","author":"Boda","year":"1999","journal-title":"Prenat Neonat Med"},{"key":"2025090503503756000_99.2.F144.27","unstructured":"Summary of product characteristics acepurin. http:\/\/db.cbg-meb.nl\/Bijsluiters\/h09974.pdf. Updated 2012."},{"key":"2025090503503756000_99.2.F144.28","doi-asserted-by":"publisher","DOI":"10.1097\/01.ftd.0000211808.74192.86"},{"key":"2025090503503756000_99.2.F144.29","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200443080-00001"},{"key":"2025090503503756000_99.2.F144.30","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.113"},{"key":"2025090503503756000_99.2.F144.31","first-page":"374","article-title":"Allopurinol reduces oxidative stress in the ovine fetal cardiovascular system after repeated episodes of ischemia-reperfusion","volume":"68","author":"Derks","year":"2010","journal-title":"Pediatr Res"},{"key":"2025090503503756000_99.2.F144.32","doi-asserted-by":"crossref","unstructured":"Kaandorp JJ Derks JB Oudijk MA . Antenatal allopurinol reduces hippocampal brain damage after acute birth asphyxia in late gestation fetal sheep. Reprod Sci 2013. doi: 10.1177\/1933719113493516","DOI":"10.1177\/1933719113493516"},{"key":"2025090503503756000_99.2.F144.33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1970.tb03405.x"}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2013-304876","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T10:50:44Z","timestamp":1757069444000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/archdischild-2013-304876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,18]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,13]]},"published-print":{"date-parts":[[2014,3]]}},"alternative-id":["10.1136\/archdischild-2013-304876"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2013-304876","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,18]]}}}